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Amyloidogenesis of proteolytic fragments of human
elastin3
DOI: 10.1039/c3ra41893f
Brigida Bochicchio,*a Antonietta Pepe,a Florian Delaunay,ab Marina Lorusso,a
Stephanie Baudcd and Manuel Dauchezcd
Some polypeptides encoded by the C-terminal region of human tropoelastin gene have been
demonstrated to be amyloidogenic in vitro. The biological relevance of this finding is still under
investigation given that only limited evidence concerning the involvement of elastin in amyloidosis exists.
Recent studies identified, by mass spectrometry, several elastin fragments produced from the cleavages
made by some elastases in human elastin substrate. Some of these fragments are contained into the same
polypeptide sequences previously demonstrated to be amyloidogenic. Our hypothesis is that the up-
regulation of elastases in inflammatory processes triggered, for example, by aging induces the release of
elastin fragments potentially amyloidogenic. Therefore our aim in this study is to demonstrate if any of
these fragments is amyloidogenic in vitro. At molecular level, CD, NMR, FTIR spectroscopies and MD
simulations were used, while, at supramolecular level, Congo red binding assay and ThT fluorescence
spectroscopy complemented with AFM microscopy were carried out. Our results show that the longest
peptide, among those synthesized and mimicking the elastin fragments produced by elastases on human
elastin, constituted of 22 residues, is able to aggregate into amyloid-like fibres. These findings support the
hypothesis of amyloidogenesis of proteolytic fragments of elastin.
Introduction
Elastin is the protein polymer responsible for elasticity in
organs and tissues such as lungs, skin and arterial walls.1–3
Tropoelastin, the soluble precursor of elastin, self-organizes
into fibres in the extracellular matrix forming a large, highly
cross-linked polymer by interacting with a number of other
extracellular matrix proteins. In most tissues elastin produc-
tion begins around the time of mid-gestation and peaks near
birth and during the early neonatal period, then drops
dramatically and is nearly completely repressed at maturity.
Elastin turn-over is almost absent in normal physiological
conditions.4 Therefore elastin is considered a long-lasting
protein that remains for life. However, elastin degradation by
enzymes up-regulated during pathological processes has been
observed.5 The degradation of elastin by elastases produces
not only a loss in elasticity of the involved tissue, but leads also
to the generation of elastin fragments that are often
biologically active. For example, elastin fragments are involved
in matrix remodelling and exhibit potent chemotactic activity
for leukocytes, stimulate fibroblast and smooth muscle cell
proliferation, and display pro-angiogenic activity as potent as
VEGF.6 Matrix metalloproteinases (MMPs) are members of a
family of enzymes capable of degrading extracellular proteins
and comprise MMP-12 that is particularly active against
elastin. High concentrations of MMP-12 are found in tissues
affected by pathologies such as chronic obstructive pulmonary
disease, abdominal aortic aneurysms7,8 and atherosclerosis.9
The abnormal levels of MMPs are also associated with skin
disorders including granulomatous skin disorders and
photoaging where MMP-12 plays an important role.10
Photodamaged skin leads to qualitative and quantitative
alterations of elastin with massive deposition of material,
referred to ‘‘elastotic material’’. This material is also observed
in arteries of atherosclerotic patients11 and in lung alveoli
where the elastotic material was shown to contain amyloid-like
fibers.12 Amyloid deposits were also identified in the vertebral
arterial wall of old subjects as they reacted only with a
polyclonal antibody to human elastin suggesting this amyloid
derived from elastin.13 This finding could be considered as the
first ex vivo evidence for the possible involvement of elastin in
amyloidogenesis. Before this study, the involvement of elastin
in amyloidogenic processes was suggested only by in vitro
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studies carried out on the polypeptide sequences encoded by
exon 28 (EX28),14 30 (EX30)15 and 32 (EX32)16 of the human
tropoelastin gene (HTE) which were demonstrated to be able
to give rise to amyloid-like fibres.14–16 Recent studies carried
out by the Schmelzer group identified the elastin-derived
peptides present in an elastase digest of insoluble human skin
elastin.17 Interestingly, polypeptide sequences encoded by
exons 28–31 were demonstrated to be present in the elastin
lysate. Given these findings and in order to address the
biological and pathological results of in vitro studies, we
hypothesise that elastin-derived soluble peptides released
from elastin by proteolytic degradation might slowly aggregate
into amyloid-like structures that could explain the amyloid
‘‘elastotic material’’ described in numerous reports. In the
present work, we chemically synthesised four peptides (S1–S4)
that have been shown to be present in the human skin elastin
digests by MMP-12 and pepsin10 and that are present in EX30
sequence (Table 1). Our aim was to assess if any of the four
peptides was able to give rise to amyloid-like fibres. CD, NMR,
FTIR, Thioflavin-T fluorescence spectroscopies, Congo-red UV
assay together with light microscopy (OM) and atomic force
microscopy (AFM) techniques were used. Results were com-
plemented with molecular dynamics (MD) simulations.
Results
CD spectroscopy
CD spectroscopy is a useful tool able to define the peptide
secondary structures. The conformational analysis of S1–S4
peptides was performed in a qualitative way by comparing the
respective curves with CD spectra of polypeptides of known
secondary structures or adopting a mixture of unknown
structures. To detect possible conformational transitions,
useful for understanding the complexity of conformer popula-
tion, the peptides were monitored by CD spectroscopy in
aqueous solution at different temperatures (Fig. 1). The CD
spectrum of S4 peptide at 0 uC was characterised by a strong
negative band at 195 nm and by a small positive band at 215
nm (Fig. 1a). The increase of the temperature to 25, 37, and 60
uC induced a slight reduction of the positive band and a strong
reduction of the negative one. The strong negative p–p* band
at 195 nm is usually attributed either to unordered or to the
left-handed poly-proline II conformation (PPII). However, its
reduction in intensity on increasing the temperature, together
with the presence of the, essentially p–p* band, at 215 nm, are
diagnostic of the PPII conformation.18–21 The loss of the
positive band together with the decrease of the negative one, at
higher temperatures, suggested the destabilisation of PPII
conformation in favour of a more folded conformation.
Indeed, the presence of the isodichroic point at 205 nm was
indicative of a conformational equilibrium between only two
conformations. The CD spectra of S3 peptide in aqueous
solution at the indicated temperatures are shown in Fig. 1b. At
0 uC S3 showed a small positive band at 214 nm and a stronger
negative one at 195 nm. Although the spectral features
indicated the presence of PPII conformation, however, the
negative band of S3 peptide was 2-fold reduced in intensity in
comparison with that of S4 (Fig. 1a). This finding suggested
that PPII conformation was present in minor amount in S3
compared with S4 peptide.
Overall, the CD spectra suggested for S3 the presence of
different conformations quickly interconverting among them.
Actually, the absence of the isoelliptic point confirmed the
presence of complex equilibria among PPII, more stable at 0
uC, unordered and b-turn conformations.22–25
The CD spectra of S1 and S2 peptides are shown in Fig. 1c
and 1d, respectively. At 0 uC the CD spectra of S1 and S2
peptides were characterised by two negative bands at 195 and
221 nm, respectively. The increase of the temperature induces
the reduction of the negative bands. These findings, together
with the absence of the positive band at 215 nm, expected for
PPII, suggested the presence of unordered and folded
conformations.
NMR spectroscopy
The S3 and S4 peptides were analysed by 1H-NMR spectroscopy
in H2O–D2O (90 : 10, v/v) at 25 uC. Even though several glycine
residues (10 : 19 and 11 : 22 for S3 and S4, respectively) were
Table 1 List of the sequences of elastin proteolytic fragments and of the parent proteases. The sequences are compared with the peptides sequences encoded by
exon 28, exon 30 and exon 32. The N-terminal (EX30N) and C-terminal portion of EX30 (EX30-18) are also included. Human tropoelastin protein sequence (Swiss Prot.
Accession number P15502.)
Peptide Sequencea Protease Amyloidogenic behaviour
S1 717LGVPGVGG724 MMP-12 No
S2 709LGGLGVGGLGVPGVGG724 MMP-12 No
S3 706AAGLGGLGVGGLGVPGVGG724 Pepsin No
S4 703LVG_A_A_GLGGLGVGGLGVPGVGG724 MMP-12 Yes
EX3012 702GLVG_A_A_GLGGLGVGGLGVPGVGGLG726 — Yes
EX30N38 702GLVG_A_A_GLGGLGVGGLG718 — Yes
EX30-1845 709LGGLGVGGLGVPGVGGLG726 — No
EX3213 740G_A_A_GLGGVLGGAGQFPLG757 — Yes
EX2811 657G_A_A_VPGVLGGLGALGGVGIPGGVV681 — Yes
Prion Peptide46 AG_A_A_AAGA — Yes
a italic: XGGZG motif; underlined: GAA motif.
present, complete resonance assignments were achieved for S3
and S4 peptide protons (Supplementary Tables S1 and S2, ESI3,
respectively). The 1H-NMR data of both peptides excluded the
presence of any folded structures. The chemical shifts of the
Ha proton resonances were all in the range usually assigned to
unordered conformations.26 No significant downfield shift
was observed, excluding the presence of relevant amount of
b-strand at 25 uC. In particular, the glycine Ha protons showed
chemical shift values in a very small range, d 3.88–3.98 ppm,
and no differences were observed for the two enantiotopic
a-protons. The 3JNH2Ha coupling constants of not-glycine
residues were in the range 5.8–7.6 Hz, usually assigned to
unordered conformations, even though they are compatible
also with PPII conformations. Only the valine residues showed
higher values, approximately 7.3–8.1 Hz, suggesting a more
extended conformation for these b-branched residues. The NH
amide proton chemical shifts are those more sensible to
environmental condition such as pH, temperature and solvent,
while the Ha proton chemical shifts are usually more sensitive
to the conformation adopted by the peptide chains. When
comparing the amide proton chemical shifts and the Ha
proton chemical shifts (Fig. 2) of S3 and S4 peptides,
important differences were observed only in the N-terminal
regions. These differences were more pronounced for the
amide protons. In order to determine the temperature
coefficients of the amide protons, 1D spectra were recorded
in the temperature range 25–45 uC. For both peptides the
temperature coefficients were lower than 25.5 ppb K21, so
excluding the presence of intramolecular H-bonds and of
b-turns.27 While the CD spectra were suggestive of a higher
content of PPII conformation in S4 peptide, these NMR data
alone were not able to define the presence and relative content
of PPII conformation. A careful NOE (Nuclear Overhauser
Fig. 1 CD spectra in aqueous solution of: S4 (a), S3 (b), S2 (c), and S1 (d) peptides at 0 uC (black); 25 uC (blue); 37 uC (green); 60 uC (red).
Fig. 2 Comparison of amide proton chemical shifts (top) and Ha proton
chemical shifts (bottom) of S3 (circles) and S4 (squares) peptides.
Effect) volume ratio analysis, between sequential daN and dNN
cross-peak volumes was carried out for defining the specific
propensities to extended conformations (b-strand and PPII) of
the single peptides. As found by Fiebig et al.28 by statistical
analysis, the random coil conformation should have a NOE
ratio daN(i,i + 1)/dNN(i,i + 1) equal to 1.4 for the sequential
backbone cross-peaks, while for the extended conformations
the higher distance of sequential amide protons should
increase the ratio to a value of 55.29 Fig. S1, ESI3 of the
Supporting Information shows the fingerprint (NH–Ha) and
the amide (NH–NH) regions of the Rotating Frame Overhauser
Effect Spectroscopy (ROESY) spectrum of S4 peptide. The
regions are displayed with the same threshold in order to
highlight differences in intensity of the cross-peaks. From the
analysis of NOE volume, we were able to define the NOE
volume ratio for some not overlapping peaks of S4 peptide,
focusing in particular on the N-terminal region. The ratio
values found for G705, A707 and L709 residues, ranging from
5.54 to 40, were significantly higher than those expected for
residues adopting random coil conformations thus suggesting
that the time spent in extended conformations (b-strand and/
or PPII) by these residues at 25 uC is significant. The same
analysis was not possible for the S3 peptide where coincidental
chemical shift values did not permit to determine the
contribution to the NOE volumes of different proton con-
nectivities. Altogether, the CD and 1H-NMR data of both
peptides pointed out the presence of highly flexible, unstruc-
tured conformations, populating different secondary struc-
tures. In order to define quantitatively the conformational
ensemble and to highlight possible differences that could
account for the different aggregation propensities observed for
S3 and S4 peptides, we measured 13C chemical shifts of the Ca
and CO backbone carbons and the Cb carbons from 2D
Heteronuclear Single Quantum Correlation (1H-13C HSQC)
and Heteronuclear Multi-Bond Connectivity (1H-13C HMBC)
spectra. The measured chemical shifts of S3 and S4 peptides
were submitted to the d2D method analysis,30 available online
(http://www-vendruscolo.ch.cam.ac.uk/d2D/index.php). The
results are shown in Fig. 3. We found that the probability to
adopt similar secondary structures from L709 to G724 in both
peptides was very high. Appreciable differences between S3
and S4 peptides were only observed at the N-terminus of S4,
where V704 and G705 showed significant probability to adopt
extended (b-sheet and/or PPII) conformations that could
trigger the amyloid–like self-assembly propensity observed
for S4 peptide.
Turbidimetry experiments
In order to investigate the aggregation properties of the
synthesised peptides, measurements of turbidimetry on
apparent absorbance (TAA) values were carried out as a
function of temperature by turbidimetry. Turbidity measure-
ments showed that, on increasing the temperature, only the S4
peptide solution gave rise to an irreversible TAA value increase
due to the aggregation of the peptide at 60 uC (Fig. S2A of
supporting information, ESI3). These findings strongly suggest
for S4 an irreversible inverse-temperature phase transition
compatible with an amyloid-like behaviour. Even if the critical
temperature observed for the phase transition is not the
physiological one, we argue that it could approach physiolo-
gical values by changing some variables, such as peptide
concentration and time. As shown in Fig. S2B, ESI3 of
supporting information, S4 peptide is able to self-aggregate
in one week at physiological temperature, and it has to be
reminded that these and longer times are compatible with
physiological/pathological events in vivo.
Thioflavin-T fluorescence assay
Thioflavin-T fluorescence assay represents a useful tool to
reveal the presence of amyloid-like fibrils. Thioflavin-T (ThT) is
a fluorescent dye suggested to bind rather selectively to the
b-sheet structures of amyloid-like fibres.31–33 The addition of
ThT to the S4 peptide solution induces an increase of the ThT
emission band centred at 482 nm, as expected for amyloid-like
fibrils (Fig. S3 in supporting information, ESI3). On the other
hand, the addition of the S1, S2 and S3 peptides to the ThT
solution does not change the fluorescence spectrum of ThT
(data not shown).
Congo red spectral shift assay
Congo red is a diazo dye that is widely used to characterise
amyloid-like fibres being its binding specifically dependent on
the secondary structure characteristic of the fibrils. It has been
demonstrated that the interaction of the Congo red with
b-pleated sheet conformation33,34 induces two effects in the
UV spectrum of peptides, the hyper-chromic effect (increase in
absorbance) and the bathochromic effect (red shift of
Fig. 3 Secondary structure populations, as obtained using the d2D method, for
S3 (top) and S4 (down) peptides; secondary structures are shown in red
(b-sheet), blue (a-helix) and green (PPII).
maximum absorbance wavelength). The interaction of S4 with
Congo red dye induced both the strong hyper-chromic and
bathochromic effects (Fig. S4 in supporting information, ESI3).
S1, S2 and S3 peptides did not produce hyper-chromic nor
bathochromic effects in the UV absorption spectrum (data not
shown).
Congo red birefringence assay
It is well known that amyloid plaques extracted from the brain
of patients affected by Alzheimers disease exhibit an apple-
green birefringence under a dark field in light microscopy.34,35
This characteristic has been ascribed to an ordered arrange-
ment of the elongated structure within the amyloid fibrils as it
is an index of a highly organised sub-structure. An aliquot of
each peptide from ‘Congo red spectral shift assay’ was
observed by light microscopy under cross-polarized light.
Only S4 peptide exhibited the apple-green birefringence
characteristic of amyloid-like fibres (Fig. 4).
FTIR spectroscopy
In FTIR spectroscopy, the amide I, due to the stretching
vibrations of the CLO group of the peptide backbone, is the
most informative region on protein secondary conformation.
Furthermore, amide I is stronger than amide II which
originates from the combination of the N–H bending and
CLO stretching modes, and than amide A modes which
originate from the N–H stretching. In the present study, only
the amide I and II modes were analysed. FTIR measurements
were carried out on the lyophilised powders of S1–S4
peptide.31 The decomposed FTIR spectra of the amide I and
II regions are shown in Fig. 5 a–e. The results are summarised
in Table S3, ESI3 of the supporting information which gives the
position, the area values and the assignment of the main
individual components of the band fits. The decomposed FTIR
spectra of the amide I region showed, for all the lyophilised
peptides, but S3, a component in the range 1625 and 1634
cm21 that could correspond to the vibrational modes of
hydrogen bonded b-turns and/or b-pleated sheets. These
components, together with the additional ones observed in
the range 1685 and 1697 cm21, could be assigned to
vibrational modes of antiparallel b-sheet conformations
compatible with the presence of the cross-b structure.36,37
The component at 1643 cm21, observed only for S3, is due to
the absorption of water usually found between 1640–1650
cm21.38 Each peptide showed in the amide I region the
presence of a component in the range between 1661 and 1667
cm21. The bands comprised in this range are usually assigned
to non-hydrogen-bonded CLO groups or groups weakly
bonded to the solvent.39 In our measurements, because of
the absence of the solvent, the band is essentially due to the
presence of PPII conformation, which is an extended structure
lacking intramolecular hydrogen bonds. Finally, the compo-
nents in the range 1648–1652 cm21 are due to the contribution
of unordered conformations. The components of decomposed
amide II region comprised in the range 1537–1539 cm21 were
tentatively assigned to unordered conformations.40 The
components in the ranges 1517–1521 cm21 and 1552–1558
cm21 could be attributed to antiparallel b-sheets.41,42 Indeed,
the peak at 1521 cm21 for S1 is normally attributed to the
dominance of the bending of hydrogen bonded NH groups in
antiparallel b-sheet structures.43 Overall, the FTIR analysis
showed for all four peptides, in lyophilised powder, the
presence of multiple conformations comprising an ensemble
of b-sheet, PPII and unordered conformations. Additionally,
FTIR measurements were carried out on S4 aggregates (Fig. 5a)
in order to gain useful insights into the secondary structure of
S4 fibres (Fig. 5a). Even if the frequencies of amide I band
components were very similar to those found for S4 lyophilised
powder, the ratio among the areas of each components
drastically changes. The total area of the bands assigned to
antiparallel b-sheet, centred at about 1630/1697 cm21, was
significantly increased in S4 fibres (Table S3, ESI3 of the
supporting information). This finding suggested that the
cross-b structure was predominant in S4 fibres. The presence
of cross-b structure was compatible with the amyloidogenic
nature of S4 aggregates. Decomposed amide I region FTIR
spectra of S3 and S4 peptides collected in D2O solution are
displayed in Fig. 5f and 5g. For S4 peptide a dominant
component at 1672 cm21 assigned to PPII conformation was
visible together with two additional minor components at 1650
and 1642 cm21 due to random coil and b-sheet conformation,
respectively. Decomposed amide I region FTIR spectrum of S3
showed two components of comparable intensities at 1673 and
1649 cm21 indicative of PPII and random coil conformations,
respectively. A minor component was found at 1638 cm21 and
assigned to b-sheet conformation. On summarising, the FTIR
spectra in D2O solution confirmed that the PPII conformation
was dominant in S4 peptide while the conformational space of
S3 peptide was equally populated by PPII and random coil
conformers, as also inferred by NMR and CD studies.
Fig. 4 Optical microscopy images of S4 fibrils stained with Congo red: bright
field (top) and dark field (bottom).
Fig. 5 Decomposed FT-IR spectra of S4 fibres (a) and of S4 (b), S3 (c), S2 (d), S1 (e) lyophilized peptides in KBr pellet. The band fitting results of amide I and II regions
are shown. Dashed line: experimental spectrum. Solid line: calculated spectrum. Decomposed FTIR spectra of amide I region in D2O solution of S4 (f) and S3 (g)
lyophilized peptides.
MD simulations
We analysed the two trajectories of S3 and S4 peptides in terms
of PPII, b-turns and b-sheet formation and interconversion, as
a function of time at the physiological temperature of 37 uC
starting from two different conformations i.e. PPII and
elongated conformation. No significant differences were found
at the level of starting conformation. The first analysis was the
computation of the radius of gyration of the peptides that
gives an idea of their overall folded state. The corresponding
results are presented in Fig. S5, ESI3 of the supporting
information, where the radius of gyration of S3 and S4 was
plotted versus time. It has been observed that for the two
peptides, the radius of gyration decreased rapidly at the
beginning of the simulations (within the first 10 ns) and
reached stable values around 7 Å, in a manner not dependent
on the starting structure. The decrease observed at the
beginning of the simulations as well as the low value of this
parameter during the simulations, attested the hydrophobicity
of the peptides that collapse on themselves in order to
optimise self-interactions and interactions with the solvent
and to adopt very compact structures. During the visualisation
of the trajectories, some transient antiparallel or parallel
b-structure could be observed only for S4 peptide at the end of
the trajectory (Fig. S5 in supporting information, ESI3). In
Fig. 6, data are reported that allowed to characterise the local
structure of the peptides during the simulations not only in
term of b-structure but also in term of PPII structure. In order
to identify the two types of structures, computations of the
dihedral angles were performed and a deviation of ¡ 30u was
tolerated around the canonical values of the (Q, y) dihedral
angle values [(Q, y) = (275u, + 145u) for the PPII structure and
(Q, y) = (2119u, + 113u) in the case of parallel b-sheet]. A more
stringent deviation of ¡ 22u was also used in order to
distinguish between PPII and parallel b-sheet, that can be
overlapping structures, using a ¡ 30u deviation. While the
presence of PPII conformation was assessed for both peptides,
the percentage of the trajectory populated by PPII was higher
for S4 peptide. Limited evidences of significant b-sheet
conformation were also observed.
Atomic Force Microscopy
AFM microscopy provides a three-dimensional characterisa-
tion of the fibrils and represents a valid tool to investigate the
presence of amyloid-like fibrils. The AFM micrographs of the
S4 peptide showed a dense network of intertwined fibrils
(Fig. 7a). A hierarchical organisation of S4 fibrils has been
observed (see arrow in Fig. 7a). In particular, it is evident that
the fibrils exhibit regular periodicity. The fibrils are often
made by two main filaments interacting side by side or
splitting into two thinner filaments. S1, S2 and S3 peptides
give rise to an amorphous peptide film (Fig. 7c–e). In
particular, Fig. 7c shows that the S3 amorphous peptide film
is characterised by circular defects ranging from 25 to 100 nm
in diameter. AFM studies definitely confirmed that among the
synthesised peptides only S4 was able to give rise to amyloid-
like fibrils. The substrate onto which the proteins are
deposited plays a tremendous role in dictating the orienta-
tion/morphology/behaviour, therefore S4 aggregates were
observed on Si as well as on mica substrate (Fig. S6 and S7
of supporting information, ESI3). In both cases, similar
intertwined fibrils were observed thus excluding the role of
substrate in the morphology of S4 aggregates.
Discussion
The results of this study show that S4 peptide, one of the
products obtained from MMP-12 proteolytic cleavage of the
human skin elastin, is able to give rise to an aggregation
process induced by environmental changes such as tempera-
ture and time. The end product of the aggregation consists of
fibres with an amyloid-like structure. The criteria adopted to
Fig. 6 Secondary structures of S3 (a) and S4 (b) peptides. The secondary
structure of the S3 and S4 peptides are evaluated in terms of PPII and b-sheet
contents as a percentage of the trajectory. Since these two configurations
correspond to similar areas in the Ramachandran plot, the content of b-sheet
(full bars) was evaluated considering Q and y angles with a deviation of ¡ 20u
from the canonical values. The content of PPII was evaluated using successively a
deviation of¡ 30u (empty bars) and of¡ 22u (dashed bars) from the canonical
values. For each peptide, we represent the secondary structure content over the
trajectory both for the elongated starting conformation (top panels of (a) and
(b)) and the PPII starting conformation (bottom panels of (a) and (b)).
assess the presence of amyloid-like fibres are well known in
the literature and are based on a combination of different
techniques. In this study, positive results for Congo red
binding assay and Congo red birefringence combined with the
presence of intertwined fibres, together with the high amount
of b-sheet structure at molecular level, assessed by FTIR
spectroscopy, are adequate evidences of an amyloid-like
aggregating S4.44
Concerning the molecular structure in aqueous solution,
representing the pre-fibrillar state of the peptide, CD, NMR,
and FTIR studies demonstrated that S4 peptide is charac-
terised by the presence of PPII conformation together with a
less represented folded conformation. The ratio of the two
conformations depends on the temperature, with the PPII
structure being preferred at 0 uC.22 For the remaining S1–S3
peptides, PPII is a minor (S3) or totally absent conformation
(S1, S2), even at low temperature. As only S4 peptide gave rise
to amyloid-like fibres, a relationship between the molecular
and supramolecular structures for peptides has been assessed
showing that the PPII conformation is fundamental in order to
have amyloid-like structures. Actually, the presence of PPII
conformation was ascertained in the pre-fibrillar state (solu-
tion state) of many other elastin-derived peptides able to self-
assemble into amyloid-like fibres.14,16 This finding is rein-
forced by studies inferring the presence of PPII conformation
in Ab(1–28)45 and Ab(12–28)46 amyloidogenic peptides.
Therefore, we consider the presence of PPII as an hallmark
for the potentially amyloidogenic behaviour of elastin pep-
tides. The presence of b-sheet conformation in the fibrils was
investigated by solid state FTIR. Since the molecular studies
carried out by CD spectroscopy gave useful insights into the
conformations involved in the prefibrillar state of S4 peptide,
FTIR let us to investigate the fibrillar state thus providing
complementary information. Solid state FTIR also allowed the
comparison between the non aggregated (S1–S4) and the
aggregated state (S4) of peptides. FTIR analyses evidenced for
all peptides a mixture of conformations consisting of PPII,
unordered and b-turn conformation together with antiparallel
b-sheet that become dominant in S4 fibres, as expected for
amyloid-like peptides47 (Fig. 5, Table S3, ESI3 of the supporting
information). On this basis, and taking into account the CD,
NMR and FTIR data, we suggest that PPII, a flexible structure
devoid of intramolecular hydrogen bonds, coexists with
b-sheet and could easily interchange into cross-b structure.48
The conformational transition from PPII to cross-b structure
could be responsible for the irreversible precipitation of the
soluble peptide into amyloid-like aggregates. Previous studies
on elastin-derived amyloidogenic peptides proposed a model
of the conformational transition from soluble protofilaments,
mainly structured in PPII conformations, to insoluble mature
fibres structured in cross-b conformation. The conformational
transition from PPII to b-sheet conformation is highly
Fig. 7 AFM micrograph of S4 fibres (a); 3D-AFM micrographs of S4 fibers (b), S3 (c), S2 (d), and S1 (e) peptides deposed on silicon wafer and observed in air.
probable given the similarity of the dihedral angle values of
the two conformations located in the upper-left region of the
Ramachandran map (Q, y) = +180u to 0u. The hypothesis made
on the aggregation mechanism involved is that the hydro-
phobic interactions due to hydrophobic amino acids (A, V, L)
are the driving force of the aggregation processes.49,50 Actually,
by increasing the temperature of the peptide the hydrophobic
interactions are favoured thus determining the transition to
the b-sheet conformation. The possibility that the formation of
b-structures gives rise to the aggregation is consistent with the
more general mechanism proposed for the formation of
amyloid fibres by proteins such as lysozyme and transthyretin
where the formation of fibres is consequence of an unfolding
process, induced by changes in microenvironment, leading to
the formation of fibres and other aggregates that accumulate
in the extracellular space.15
The role played by the peptide secondary structure in the
amyloid-like self-aggregation process is strictly connected to
the peptide sequence. Generally, proline-rich elastin-derived
peptides self-aggregate upon heating in a reversible process,
known as coacervation, as tropoelastin does. The peptide
coacervate is constituted by hierarchical fibrous organisation
very similar to the supramolecular structure exhibited by the
entire protein.51,52 On the other hand, some glycine-rich
elastin-derived peptides, upon heating, give rise to an
irreversible self-aggregation process whose final aggregates
are, at supramolecular level, intertwined fibres similar to
amyloid-like filaments.53 Among glycine-rich elastin-derived
peptides, EX30 containing all the four synthesised peptides
S1–S4, was demonstrated to self-aggregate into amyloid-like
fibrils.15 The different behaviour of proline and glycine-rich
elastin-derived peptides has been recently rationalised by
experimental and Molecular Dynamic studies.54,55 The analy-
sis is mainly based on the glycine and proline content of the
peptides: the hindered proline and the flexible glycine, the
most abundant amino acidic residues in elastin, play a crucial
role in triggering the self-aggregation properties of elastin-
derived peptides.14,55,56 According to Pomes,55 the sequence
analysis of some elastin sequences shows a threshold in
proline and glycine composition above which amyloid forma-
tion is impeded and elastomeric properties become apparent.
In our case, EX30 peptide reveals a P and G composition
consistent with a grey region where both amyloidogenic and
elastomeric properties can coexist. By adopting the same
analysis we find that the gradual lengthening of the sequence
from S1 to S4 reduces the P percentage content thus conferring
to the longer peptides a progressive increase of the amyloido-
genic properties, according to our experimental data (Table S4,
ESI3 of the supporting information). In the present work the
issue of a better understanding of the sequence-structure
relationship for amyloidogenic elastin-derived peptides has
been addressed. Indeed, previous studies have demonstrated
that the propensity of elastin-derived peptides to aggregate in
amyloid-like fibres is dependent on the primary structure of
the peptide. Accordingly, the elastin-derived peptides contain-
ing the XGGZG (X, Z = V, L, A) motif, tandem or twice repeated,
were demonstrated to adopt an amyloid-like structure that was
considered responsible for their amyloidogenic behavior.16
Furthermore, the peptide sequences containing this motif are
widely found in many proteins such as collagens IV and XVII,
fibrillin 2 precursor, flagelliform silk protein, major ampullate
gland dragline silk protein, major prion protein precursor,
lamprin precursor, as well as in amyloid AbA4 precursor
protein-binding family. Concerning the peptides synthesised
in this work, it is worth of note that all the peptide sequences
listed in Table 1, but S1 peptide, contain the motif XGGZG (X,
Z = V, L, A) tandem repeated along the peptide sequence.
However, even if this finding is in good agreement with the
amyloidogenic nature of S4, it does not explain the different
behaviour of S3 and S2 peptides when compared to S4. S4
differs from S3 only in three additional residues (L703V704G705)
located at the N-terminus of the sequence. In this way, a G705
A706 A707 triplet is introduced in the longer S4 sequence
(Table 1).
Interestingly, the GAA motif is also found in EX28,14
EX30,15 EX30N48 and EX3216 elastin sequences previously
demonstrated to be amyloidogenic, as well as in the highly
amyloidogenic AGAAAAGA peptide57 (Table 1). Therefore, it
could be speculated that the GAA motif could be responsible
for the major amount of PPII conformation found for S4 in
comparison with S3, as inferred by CD studies, and respon-
sible for S4 amyloidogenic behaviour.
In order to support this finding, NMR and MD analyses
focused the attention on the N-terminal region. Essentially,
NMR and MD results confirm the CD insights suggesting for
S4 peptide a higher propensity, in comparison with S3, to
adopt the PPII conformation due to A706 and A707 residues. In
particular, by using 1H and 13C chemical shifts of S3 and S4
peptides, an attempt to define quantitatively the different
secondary structures populated by the residues was made. The
use of chemical shifts for the identification of secondary
structures in the native state of globular proteins has been
long recognised.26,58 In the case of disordered or natively
unstructured states of proteins and peptides, the quantitative
identification of the secondary structures uniquely based on
the backbone chemical shifts was a demanding task.30
Recently, Camilloni et al. developed a new method, based on
the backbone chemical shifts of disordered states of proteins,
that has been applied on several unstructured states of
proteins.30 The d2D method is very useful to identify the
probability of the distribution of heterogeneous secondary
structures defining the conformational ensemble populating
the proteins. In our case the d2D method suggests a significant
propensity to extended conformations (b-sheet and PPII) for
the N-terminal residues of S4 (Fig. 3) and this could account
for the increased aggregation propensities observed for S4
peptide.
In order to have additional insights into different aggrega-
tion propensity of S3 and S4 peptides, we submitted our
sequences to several servers, hosting softwares aimed to
predict and/or to identify, inside the peptide sequences, the
segments more prone to aggregation. A systematic search,
employing several available software [BETASCAN,59 TANGO,60
AmylPred,61 FoldAmyloid,62 AGGRESCAN,63 WALTZ,64
Zyggregator65] [reviewed in66] evidenced similar results.
According to AGGRESCAN results, the regions with a higher
propensity to adopt b-sheet structures are G705–A707 and L713–
V719 in S4, while in S3 only the latter region was identified as
prone to aggregation. Similar results have been achieved by
Zyggregator analysis. According to Zyggregator, S4 shows two
regions with high aggregation propensities (those above the
ZAgg = 1 threshold, dotted line in Fig. 8): the N-terminal region
A706–A707, absent in the S3 peptide, and the G710–G716 regions,
present also in the S3 peptide.
Even if the theoretical results are to be considered with
great caution, nevertheless they confirm our experimental data
suggesting that the N-terminal region of the two peptides have
different aggregation propensities that could account for the
observed results. Now, we would like to discuss, admittedly in
a speculative manner, the possible relevance of these findings
to some pathologies that affect elastic tissues and where
MMP2 protein and activity were found (e.g. atherosclerosis,
chronic obstructive pulmonary disease, abdominal aortic
aneurysms). Therefore, elastin can potentially release amyloi-
dogenic fragments by up-regulating proteolytic enzymes in
pathological conditions and in ageing.
We have shown that elastin proteolytic fragments are
potentially able to form amyloid-like aggregates at physiologi-
cal temperature and times. However, clear clinical evidences
that elastin-related amyloids are involved in pathological
conditions are lacking. In the arterial wall fragments of
various proteins were involved in the age-related amyloid
deposition. In particular, medin, a fragment derived from
lactadherin expressed by smooth muscle cells, aggregates into
amyloid in certain arteries, particularly the thoracic aortic
media layer.67 Immunohistochemical findings showed that
medin amyloid co-localizes with elastic fibres in arteries67 and
increases the production of metalloproteinases, thus favouring
elastin and collagen degradation.68
Conclusion
Elastin self-assembles into fibres and bundles of filaments
that are crucial for its biological function and appear as
twisted-rope and very different from the amyloid-like fibrils
formed by some elastin-derived peptides. In this work we have
shown that one peptide, among the four synthesised, is able to
give rise to amyloid-like fibrils, in vitro, as a function of
temperature and time. This finding supports the initial
hypothesis well, suggesting that elastin is involved in
amyloidogenesis only when elastin-derived peptides are
released from the protein, for example by the action of
proteases up-regulated in ageing and in pathological pro-
cesses. Among the assayed peptides, S4 seems to have the
highest propensity to produce amyloid-like structures due to
the GAA motif responsible for the prevalent PPII conformation
of the peptide.
Experimental section
Peptide synthesis and purification
The peptides were synthesised by solid-phase methodology
using an automatic synthesiser APPLIED BIOSYSTEM model
431 A. Fmoc/DCC/HOBT chemistry was used, starting from
(0.25 mmol) Wang resin (Nova Biochem, Laufelfingen,
Switzerland). The Fmoc-amino acids were purchased from
Nova Biochem (Laufelfingen, Switzerland) and from Inbios
(Pozzuoli, Italy). The cleavage of the peptides from resin was
achieved by using an aqueous mixture of 95% trifluoroacetic
acid. The peptides were lyophilised and purified by reversed-
phase HPLC (high performance liquid chromatography).
Binary gradient was used, and the solvents were H2O (0.1%
TFA) and CH3CN (0.1% TFA). The purity of peptides was
assessed by electrospray mass spectrometry.
CD spectroscopy
CD spectra of peptides (0. 1 mg ml21) were acquired at
different temperatures with a Jasco J-815 Spectropolarimeter
equipped with a HAAKE thermostat as temperature controller
by using 0.1 cm path length quartz cell. Samples were
equilibrated at the temperature for 5 min before acquisition.
Spectra were acquired by taking points every 0.1 nm, with 100
nm min21 scan rate, 16 scans, an integration time of 2 s, and a
1 nm bandwidth. The data are expressed in terms of [h]MRW,
the mean residue ellipticity value as deg cm2 dmol21, in order
to compare the data obtained for different peptide lengths.
NMR spectroscopy
All NMR experiments were performed on a Varian Unity INOVA
500 MHz spectrometer equipped with a 5 mm triple-resonance
probe and z-axial gradients. The purified peptides were
dissolved in 700 mL H2O–D2O (90 : 10, v/v) containing 0.1
mM 3-(trimethyl-sily1)-1-propane sulfonic acid (DSS) as inter-
nal reference standard at 0 ppm. 3 mM peptide solutions were
used. One-dimensional spectra were acquired in Fourier mode
with quadrature detection and the water signal was sup-
pressed by double-pulsed field-gradient spin-echo.58 Two-
Fig. 8 Aggregation propensity profiles of S3 and S4 sequences. The vertical bars
indicate the intrinsic aggregation profile of S3 (gray dashed) and S4 (black)
peptides.
dimensional Total Correlation Spectroscopy (TOCSY59) and
ROESY60 spectra were collected in the phase-sensitive mode
using the States method. Typical data were 2048 complex data
points, 32 or 64 transients and 256 increments. Relaxation
delays were set to 2.5 s and spinlock (MLEV-17) mixing time
was 80 ms for TOCSY while 200–300 ms mixing time was
applied to ROESY experiments. Shifted sine bell squared
weighting and zero filling to 2 K 6 2 K was applied before
Fourier transform. Amide proton temperature coefficients
were usually measured from 1D 1H NMR spectra recorded in 5
uC increments from 20 uC to 45 uC. Data were processed with
VNMRJ 2.2D. 1H Sequential resonance assignments were made
by the approach described by Wu¨thrich.61 The 2D 1H–13C
gradient heteronuclear single quantum correlation (adiabatic
version) (gHSQCAD) and the gradient heteronuclear multi-
bond connectivity (adiabatic version) (gHMBCAD) experiments
were carried out with the natural abundance of 13C in the S3
and S4 peptides using the pulse sequences from the Varian
user library. The 13C resonances were assigned through the 2D
1H–13C HSQC and 1H–13C HMBC spectra by using the assigned
1H chemical shifts for proton resonances.
Turbidimetry experiments
1.5 ml of 1 mM solutions of the synthesised peptides in TBS
buffer [Tris (50 mM), NaCl (1.5 M), and CaCl2 (1.0 mM) (pH
7.0)] were analysed by turbidimetry at 440 nm as function of
temperature and at 37 uC as a function of time for one week on
a Cary 50 UV spectrophotometer equipped with a Peltier
temperature controller using quartz cells of 1 cm path length
and reported as TAA (turbidimetry on apparent absorbance).
The solution temperature was increased from 10 to 90 uC with
2 uC every 5 min then decreased back to 10 uC, monitoring the
absorbance under stirring after 5 min to reach the temperature
equilibrium.
Thioflavin T (ThT) fluorescence assay
The assay for binding of thioflavin-T was performed according
to the method of LeVine.57 ThT fluorescence emission was
measured with excitation at 440 nm between 460 and 500 nm
with 5 nm slit widths using a JOBIN YVON-SPEX FUOROLOG-3
spectrofluorometer. A stock solution of 2.5 mM Thioflavin T
(ThT) was prepared in TBS buffer and filtered by a 0.22 mm
filter. 1 ml ThT stock solution was added to 50 ml TBS to a
final concentration of 50 mM. Fluorescence spectra in the
presence of peptides recovered from turbidimetry were
measured. The spectrum of peptide alone was subtracted
from the spectrum of the ThT solution with peptide to
normalise the fluorescence of the sample by subtracting the
blank sample.
Congo red spectral shift assay
The procedure described by Klunk et al.31 was followed, with
minor modifications. A Congo red stock solution (1.25 mM)
was prepared in TBS buffer–ethanol (8 : 2, v/v) at pH 7.4 and
filtered by using a 0.22 mm filter. From this stock solution, a
diluted Congo red solution was prepared (0.125 mM). Aliquots
(0.350 ml) taken from peptide suspensions recovered from
turbidimetry experiment in TBS were combined with 0.350 ml
of the Congo red solution (0.125 mM). The peptide suspen-
sions were stirred, and an absorbance spectrum from 400 to
600 nm was collected with a NIR-UV O5 Cary UV spectro-
photometer using quartz cells of 1 cm path length and TBS as
reference solution. The spectrum of peptide alone was
subtracted from the spectrum of Congo Red with peptide to
correct for the turbidity of the sample due to the precipitated
material.
Congo red birefringence assay
50 ml of each polypeptide solution previously analysed by
Congo red binding assay, were deposited onto a glass slide and
air-dried at room temperature. The slides were observed at 40X
magnification. The stained samples were examined under
polarised light with a Nikon ECLIPSE E600 POL microscope
equipped with Nikon Cool Pix 4500 4.0 Mega Pixel.
FTIR spectroscopy
The synthesised peptides were analysed by FTIR in KBr pellets
(1 mg 100 mg21) as a powder. S4 peptide was also analysed as
precipitated fibres. The spectra were recorded on a Jasco FTIR-
460 PLUS using a resolution of 2 cm21 and and 256 scan, then
smoothed by using the Savitzky–Golay algorithm. S3 and S4
peptides were analysed in D2O solution (5 mg ml
21) by using
CaF2 cells of 200 micron path length. The decomposition of
FTIR spectra was obtained using the peak fitting module
implemented in the Origin Software (Microcalc Inc.) using the
second derivative method. In the curve fitting procedure, the
Voigt peak shape has been used for all peaks. The Voigt shape
is a combination of the Gaussian and Lorentzian peak shapes
and accounts for the broadening present in the FTIR
spectrum.
MD simulations
MD simulations were focused on the S3 and S4 peptides as
they are the two longest peptides. The simulations were
performed in water (explicit solvent) and in boxes with the
following dimensions 356 356 90 Å3. The simulations refer
to single molecule and its conformational changes. All the
calculations were performed on the regional computing
platform ROMEO2 (http://www.romeo2.fr/), constituted of 11
nodes for a total of 108 cores (400 GB RAM). Processors are
dual-core Intel Itanium II (Montecito) possessing 8 MB cache
with a 1.6 GHz frequency. The cluster of the Multi-scale
Molecular Modelling Platform was also used (2 6 8 cluster
vision CPU).The simulations are 100 ns long. Each peptide was
generated using the RIBOSOME V1.0 program (http://rose-
lab.jhu.edu/yraj/Manuals/ribosome.html). Two starting con-
formations were generated for the two peptides; both
elongated and PPII structures were considered as the starting
point. Each of these structures are characterised by specific
values of the torsions angles of the residues along the
sequence: the canonical (Q = 2180u; y = + 180u) values were
used in the case of the elongated starting configuration
whereas the canonical (Q = 275u; y = + 145u) values were used
in the case of the PPII starting structure. First, the peptides
were placed in TIP3 water box.62 The extended conformation of
S4 in water contains 10 859 atoms and 3533 water molecules.
Concerning S3, while the number of atoms per box is very
similar to S4, the number of solvent molecules is higher as the
peptide is shorter than S4. We did not perform replicate runs.
Periodic boundary conditions were applied during all stages of
the simulation. The water molar ratio was not taken into
account in the simulations. Since we have run single peptide
simulations, the size of the box was chosen so that the peptide
would not interact with its images when we apply the periodic
boundary conditions. The entire solute–solvent system was
minimised, by applying 500 steps of energy minimisation
using the steepest descent algorithm. The system was then
heated to 310 K and molecular dynamics simulations were
performed using the GROMACS software Version 4.0.7, using
the OPLSAA63 force-field, on a supercomputer of the ROMEO2
platform. The Verlet algorithm was used to integrate the
equations from classical mechanics, in parallel with an
integration step of 2 fs since we froze the length of the bonds
implicating hydrogen atoms. For the nonbonded terms, we
used the Particle Mesh Ewald (PME) algorithm with a cut off at
1.49 Å for the coulombic interactions and a potential-shifting
function for van der Waals interactions applied at 1.3 Å and a
cut off at 1.4 Å.
Atomic Force Microscopy (AFM)
At the end of the warming cycle of turbidity assay, the
suspension was centrifuged and the supernatant was removed.
The pellet was washed with ultra-pure water, centrifuged and
the supernatant removed. The process was repeated twice in
order to remove salts. 10 microliters of the suspension was
deposited on Silicon (100) wafer substrate (Aldrich, Saint
Louis, Mo, USA) and on Mica squares, 0,15 mm thickness, size
15 mm 6 15 mm (NT-MDT America Inc. Santa Clara, CA
95054, USA). The silicon wafers were cleaned by using a two-
solvent method consisting in the immersion of the Si wafer in
warm acetone bath for a period of 10 min. Then a methanol
bath for a period of 5 min immediately followed with final
deionized water rinses. The samples were air-dried and
repeatedly rinsed with ultra-pure water in order to remove
salts. After water evaporation, the AFM images were carried out
by using the XE-120 microscope (Park Systems) in air and at
room temperature. Data acquisition was carried out in
intermittent contact mode at scan rates between 0.4 and 3
Hz, using rectangular Si cantilevers (NCHR, Park Systems)
having the radius of curvature less than 10 nm and with the
nominal resonance frequency and force constant of 330 kHz
and 42 N m21, respectively, or diamond tips (Mikromasch)
with typical spike curvature radius less than 7 nm, nominal
resonance frequency of 325 kHz, and typical force constant 46
N m21.
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